Evicenter
MarkdownMedical informationP&T meetings
Ivonescimab

EGFR-mutated non-small-cell lung cancer

Launch
Not announced
Last updated
73 sources

Section 6 of 6

References

73 sources

  1. Akeso (2026) (opens in a new tab)
  2. Akeso ivonescimab package insert (opens in a new tab)
  3. Akeso ivonescimab product page (opens in a new tab)
  4. Al Matairi et al. (2025) (opens in a new tab)
  5. CDC (2026) (opens in a new tab)
  6. Chen et al. (2025) (opens in a new tab)
  7. Cheng et al. (2025) (opens in a new tab)
  8. Chiu et al. (2022) (opens in a new tab)
  9. Dai et al. (2026) (opens in a new tab)
  10. Dhillon (2024) (opens in a new tab)
  11. Fang et al. (2025) (opens in a new tab)
  12. FDA (2018) (opens in a new tab)
  13. FDA (2024) (opens in a new tab)
  14. FDA (2025) (opens in a new tab)
  15. Frentzas et al. (2024) (opens in a new tab)
  16. HARMONi-A Study Investigators (2024) (opens in a new tab)
  17. HARMONi-A Study Investigators (2026) (opens in a new tab)
  18. IASLC (2025) (opens in a new tab)
  19. JAMA Research Summary (2026) (opens in a new tab)
  20. Jing et al. (2026) (opens in a new tab)
  21. Le et al. (2026a) (opens in a new tab)
  22. Le et al. (2026b) (opens in a new tab)
  23. Lee et al. (2024) (opens in a new tab)
  24. Leighl et al. (2026) (opens in a new tab)
  25. Liu et al. (2025) (opens in a new tab)
  26. Long et al. (2025) (opens in a new tab)
  27. Malapelle et al. (2025) (opens in a new tab)
  28. MedlinePlus Genetics (opens in a new tab)
  29. MedlinePlus lung cancer genetic tests (opens in a new tab)
  30. MedlinePlus non-small cell lung cancer (opens in a new tab)
  31. Mo et al. (2025) (opens in a new tab)
  32. Mok et al. (2024) (opens in a new tab)
  33. National Cancer Institute (opens in a new tab)
  34. National Cancer Institute (2021) (opens in a new tab)
  35. National Medical Products Administration (2025) (opens in a new tab)
  36. Pan et al. (2025) (opens in a new tab)
  37. Pang et al. (2025) (opens in a new tab)
  38. Passaro et al. (2024) (opens in a new tab)
  39. Patel et al. (2026) (opens in a new tab)
  40. PDQ Adult Treatment Editorial Board (2025) (opens in a new tab)
  41. Peled et al. (2025) (opens in a new tab)
  42. Sands et al. (2025) (opens in a new tab)
  43. Summit Therapeutics Akeso partnership page (opens in a new tab)
  44. Summit Therapeutics BLA acceptance announcement (2026) (opens in a new tab)
  45. Summit Therapeutics BLA submission announcement (2026) (opens in a new tab)
  46. Summit Therapeutics China NMPA approval announcement (2024) (opens in a new tab)
  47. Summit Therapeutics complete response letter announcement (2026) (opens in a new tab)
  48. Summit Therapeutics ELCC 2026 presentations announcement (2026) (opens in a new tab)
  49. Summit Therapeutics expanded access page (opens in a new tab)
  50. Summit Therapeutics Form 10-K (2025) (opens in a new tab)
  51. Summit Therapeutics Form 10-Q (2026) (opens in a new tab)
  52. Summit Therapeutics HARMONi enrollment completion announcement (2024) (opens in a new tab)
  53. Summit Therapeutics HARMONi enrollment fact sheet (2025) (opens in a new tab)
  54. Summit Therapeutics HARMONi longer-term follow-up announcement (2025) (opens in a new tab)
  55. Summit Therapeutics HARMONi progression-free survival announcement (2025) (opens in a new tab)
  56. Summit Therapeutics HARMONi trial page (opens in a new tab)
  57. Summit Therapeutics HARMONi updated overall survival announcement (2026) (opens in a new tab)
  58. Summit Therapeutics HARMONi-A overall survival announcement (2025) (opens in a new tab)
  59. Summit Therapeutics ivonescimab overview page (opens in a new tab)
  60. Sun et al. (2026) (opens in a new tab)
  61. Vanderpoel et al. (2023) (opens in a new tab)
  62. Vyas et al. (2026) (opens in a new tab)
  63. Wang et al. (2024) (opens in a new tab)
  64. Wang et al. (2025) (opens in a new tab)
  65. Waterhouse et al. (2025) (opens in a new tab)
  66. Yang et al. (2024) (opens in a new tab)
  67. Yang et al. (2025) (opens in a new tab)
  68. Yang et al. (2026) (opens in a new tab)
  69. Zhang et al. (2025) (opens in a new tab)
  70. Zhao et al. (2023) (opens in a new tab)
  71. Zhong et al. (2025) (opens in a new tab)
  72. Zhou et al. (2026) (opens in a new tab)
  73. Zhu et al. (2026) (opens in a new tab)